Since the inception of radionuclide therapies by John Lawrence and Saul Hertz over 80 y ago, little has changed regarding dosing strategies. We tend to use empirical amounts of therapeutic radionuclide administered at fixed intervals or as a single treatment, with little regard to an individual
Bailey et al. (Thu,) studied this question.